Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Jan 2, 2009 | Agrisoma Biosciences | Series Unknown | — | Biotechnology | — |
Sep 3, 2008 | Natrix Separations | Series B | — | Biotechnology | — |
Jul 30, 2008 | Cytochroma | Series C | — | Biotechnology | — |
Jul 3, 2008 | Gemin X Pharmaceuticals | Series C | — | Biotechnology | — |
Jun 2, 2008 | Inimex Pharmaceuticals | Series B | — | Biotechnology | — |
Jan 10, 2008 | ViOptix | Series D | — | Biotechnology | — |
Jul 6, 2007 | Protiva Biotherapeutics | Series Unknown | — | Biotechnology | — |
Jul 13, 2006 | Protiva Biotherapeutics | Series C | — | Biotechnology | — |
Jan 1, 2006 | PharmAthene | Post-IPO Equity | — | Biotechnology | — |
May 12, 2005 | Ambit Biosciences | Series C | — | Biopharma | — |
Dec 8, 2004 | Inimex Pharmaceuticals | Series A | — | Biotechnology | — |
Jul 6, 2004 | Inimex Pharmaceuticals | Series A | — | Biotechnology | — |
Mar 4, 2002 | Aegera Therapeutics | Series Unknown | — | Biotechnology | — |
Dec 18, 2001 | Cytochroma | Series B | — | Biotechnology | — |
Oct 30, 2001 | Cytochroma | Series B | — | Biotechnology | — |
Feb 1, 1999 | Cytochroma | Series A | — | Biotechnology | — |
Jan 1, 1999 | MethylGene | Series Unknown | — | Biopharma | — |